Baiyunshan
Baiyunshan, officially known as Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, is a prominent player in the pharmaceutical industry, headquartered in Guangzhou, China. Established in 1997, the company has made significant strides in the development and production of traditional Chinese medicine, Western pharmaceuticals, and health products, catering to both domestic and international markets. With a strong focus on research and innovation, Baiyunshan offers a diverse range of core products, including herbal remedies and modern pharmaceuticals, distinguished by their quality and efficacy. The company has achieved notable recognition within the industry, positioning itself as a leader in the integration of traditional and modern medicinal practices. Baiyunshan continues to expand its operational footprint, contributing to the advancement of healthcare solutions in China and beyond.
DitchCarbon Score
How does Baiyunshan's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baiyunshan's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Baiyunshan's reported carbon emissions
In 2022, Baiyunshan, headquartered in China, reported no specific carbon emissions data, including Scope 1, 2, or 3 emissions. The company has not disclosed any reduction targets or climate commitments, indicating a lack of formalised climate strategy at this time. Baiyunshan's emissions data is not cascaded from any parent organisation, and there are no significant climate initiatives or pledges currently in place. The absence of disclosed emissions figures suggests that the company may be in the early stages of developing its climate action framework. As the pharmaceutical industry increasingly prioritises sustainability, Baiyunshan may need to establish clear emissions reduction targets and commitments to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baiyunshan is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
